Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 1.67 USD -7.73% Market Closed
Market Cap: 21.2m USD

Collplant Biotechnologies Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Collplant Biotechnologies Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Cash from Operating Activities
-$9.9m
CAGR 3-Years
8%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Cash from Operating Activities
$28.3m
CAGR 3-Years
19%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Cash from Operating Activities
-$137.7m
CAGR 3-Years
-17%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Cash from Operating Activities
-$7m
CAGR 3-Years
19%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Pluri Inc
NASDAQ:PLUR
Cash from Operating Activities
-$19.6m
CAGR 3-Years
18%
CAGR 5-Years
5%
CAGR 10-Years
1%
M
Matricelf Ltd
TASE:MTLF
Cash from Operating Activities
-₪11.8m
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Collplant Biotechnologies Ltd
Glance View

Market Cap
21.3m USD
Industry
Biotechnology

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

CLGN Intrinsic Value
HIDDEN
Show

See Also

What is Collplant Biotechnologies Ltd's Cash from Operating Activities?
Cash from Operating Activities
-9.9m USD

Based on the financial report for Sep 30, 2025, Collplant Biotechnologies Ltd's Cash from Operating Activities amounts to -9.9m USD.

What is Collplant Biotechnologies Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-17%

Over the last year, the Cash from Operating Activities growth was 23%. The average annual Cash from Operating Activities growth rates for Collplant Biotechnologies Ltd have been 8% over the past three years , -17% over the past five years .

Back to Top